Literature DB >> 8889333

AIDS and Leishmania infantum. New approaches for a new epidemiological problem.

J Alvar1, B Gutiérrez-Solar, I Pachón, E Calbacho, M Ramírez, R Vallés, J L Guillén, C Cañavate, C Amela.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8889333     DOI： 10.1016/0738-081x(96)00046-6

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  12 in total

1.  Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Authors:  Tesfaye Gelanew; Zewdu Hurissa; Ermias Diro; Aysheshm Kassahun; Katrin Kuhls; Gabriele Schönian; Asrat Hailu
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  AIDS and leishmaniasis.

Authors:  R N Davidson
Journal:  Genitourin Med       Date:  1997-08

3.  Molecular fingerprinting of Leishmania infantum strains following an outbreak of visceral leishmaniasis in central Israel.

Authors:  Abedelmajeed Nasereddin; Gad Baneth; Gabriele Schönian; Moein Kanaan; Charles L Jaffe
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.

Authors:  Y Le Fichoux; D Rousseau; B Ferrua; S Ruette; A Lelièvre; D Grousson; J Kubar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.

Authors:  A Boarino; A Scalone; L Gradoni; E Ferroglio; F Vitale; R Zanatta; M G Giuffrida; S Rosati
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

7.  Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

Authors:  J A Pineda; J A Gallardo; J Macías; J Delgado; C Regordán; F Morillas; F Relimpio; J Martín-Sánchez; A Sánchez-Quijano; M Leal; E Lissen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Drug resistance in leishmaniasis.

Authors:  Jaya Chakravarty; Shyam Sundar
Journal:  J Glob Infect Dis       Date:  2010-05

9.  Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa Leishmania infantum recombinant polypeptide.

Authors:  Claudia Abeijon; Nada Daifalla; Greice Krautz-Peterson; Stefano Pizzirani; Gillian Beamer; Neuza M Frazatti-Gallina; Isaias Raw; Antonio Campos-Neto
Journal:  Trials Vaccinol       Date:  2016

Review 10.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.